AU2003222606A1 - Diagnosis of carcinoma using raigi polypeptides - Google Patents
Diagnosis of carcinoma using raigi polypeptidesInfo
- Publication number
- AU2003222606A1 AU2003222606A1 AU2003222606A AU2003222606A AU2003222606A1 AU 2003222606 A1 AU2003222606 A1 AU 2003222606A1 AU 2003222606 A AU2003222606 A AU 2003222606A AU 2003222606 A AU2003222606 A AU 2003222606A AU 2003222606 A1 AU2003222606 A1 AU 2003222606A1
- Authority
- AU
- Australia
- Prior art keywords
- polypeptide
- cancer
- carcinoma
- diagnosis
- raigi
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 229920001184 polypeptide Polymers 0.000 title abstract 7
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 7
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 7
- 201000009030 Carcinoma Diseases 0.000 title abstract 2
- 238000003745 diagnosis Methods 0.000 title abstract 2
- 101001100101 Homo sapiens Retinoic acid-induced protein 3 Proteins 0.000 abstract 2
- 102100038453 Retinoic acid-induced protein 3 Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 206010006187 Breast cancer Diseases 0.000 abstract 1
- 208000026310 Breast neoplasm Diseases 0.000 abstract 1
- 206010009944 Colon cancer Diseases 0.000 abstract 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 abstract 1
- 206010033128 Ovarian cancer Diseases 0.000 abstract 1
- 206010061535 Ovarian neoplasm Diseases 0.000 abstract 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 208000029742 colonic neoplasm Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 201000007270 liver cancer Diseases 0.000 abstract 1
- 208000014018 liver neoplasm Diseases 0.000 abstract 1
- 201000005202 lung cancer Diseases 0.000 abstract 1
- 208000020816 lung neoplasm Diseases 0.000 abstract 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 201000008968 osteosarcoma Diseases 0.000 abstract 1
- 201000002528 pancreatic cancer Diseases 0.000 abstract 1
- 208000008443 pancreatic carcinoma Diseases 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 238000012216 screening Methods 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Hospice & Palliative Care (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pulmonology (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Physical Education & Sports Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0208331.9 | 2002-04-11 | ||
| GB0208331A GB0208331D0 (en) | 2002-04-11 | 2002-04-11 | Proteins |
| GB0221538A GB0221538D0 (en) | 2002-09-17 | 2002-09-17 | A protein involved in carcinoma |
| GB0221538.2 | 2002-09-17 | ||
| PCT/GB2003/001587 WO2003087832A2 (en) | 2002-04-11 | 2003-04-10 | Diagnosis of carcinoma using raigi polypeptides |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2003222606A8 AU2003222606A8 (en) | 2003-10-27 |
| AU2003222606A1 true AU2003222606A1 (en) | 2003-10-27 |
Family
ID=29252443
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003222606A Abandoned AU2003222606A1 (en) | 2002-04-11 | 2003-04-10 | Diagnosis of carcinoma using raigi polypeptides |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20050282165A1 (enExample) |
| EP (1) | EP1497656B1 (enExample) |
| JP (2) | JP2005522226A (enExample) |
| AT (1) | ATE347106T1 (enExample) |
| AU (1) | AU2003222606A1 (enExample) |
| DE (1) | DE60310059T2 (enExample) |
| ES (1) | ES2274220T3 (enExample) |
| WO (1) | WO2003087832A2 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040121362A1 (en) * | 2002-06-20 | 2004-06-24 | Whitney Gena S. | Identification and modulation of a G-protein coupled receptor (GPCR), RAI-3, associated with chronic obstructive pulmonary disease (COPD) and NF-kappaB and E-selectin regulation |
| WO2021045224A1 (ja) * | 2019-09-04 | 2021-03-11 | 国立大学法人東海国立大学機構 | がん免疫療法等における免疫関連有害事象の予測 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030068618A1 (en) * | 2000-07-26 | 2003-04-10 | Muralidharu Padigaru | Novel proteins and nucleic acids encoding same |
| US6812339B1 (en) * | 2000-09-08 | 2004-11-02 | Applera Corporation | Polymorphisms in known genes associated with human disease, methods of detection and uses thereof |
| AU2002253878A1 (en) * | 2001-01-25 | 2002-08-06 | Gene Logic, Inc. | Gene expression profiles in breast tissue |
| AU2002324451A1 (en) * | 2001-06-21 | 2003-01-08 | Millennium Pharmaceuticals, Inc. | Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast and ovarian cancer |
-
2003
- 2003-04-10 EP EP03717443A patent/EP1497656B1/en not_active Expired - Lifetime
- 2003-04-10 DE DE60310059T patent/DE60310059T2/de not_active Expired - Lifetime
- 2003-04-10 US US10/510,507 patent/US20050282165A1/en not_active Abandoned
- 2003-04-10 WO PCT/GB2003/001587 patent/WO2003087832A2/en not_active Ceased
- 2003-04-10 AT AT03717443T patent/ATE347106T1/de not_active IP Right Cessation
- 2003-04-10 ES ES03717443T patent/ES2274220T3/es not_active Expired - Lifetime
- 2003-04-10 AU AU2003222606A patent/AU2003222606A1/en not_active Abandoned
- 2003-04-10 JP JP2003584724A patent/JP2005522226A/ja active Pending
-
2007
- 2007-11-26 US US11/986,786 patent/US20090258019A1/en not_active Abandoned
-
2009
- 2009-12-16 JP JP2009284846A patent/JP2010117358A/ja not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20090258019A1 (en) | 2009-10-15 |
| ATE347106T1 (de) | 2006-12-15 |
| DE60310059T2 (de) | 2007-05-10 |
| ES2274220T3 (es) | 2007-05-16 |
| JP2005522226A (ja) | 2005-07-28 |
| EP1497656B1 (en) | 2006-11-29 |
| WO2003087832A2 (en) | 2003-10-23 |
| AU2003222606A8 (en) | 2003-10-27 |
| WO2003087832A3 (en) | 2004-02-12 |
| JP2010117358A (ja) | 2010-05-27 |
| EP1497656A2 (en) | 2005-01-19 |
| DE60310059D1 (de) | 2007-01-11 |
| US20050282165A1 (en) | 2005-12-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2001008636A8 (en) | Polypeptides and polynucleotides for enhancing immune reactivity to her-2 protein | |
| ATE519847T1 (de) | Il-17-homologe polypeptide und ihre therapeutische verwendung | |
| EA200101037A1 (ru) | Соединения и способы для лечения и диагностики рака легкого | |
| WO2002078598A3 (en) | Peptides and antibodies to muc 1 proteins | |
| DK0981618T4 (da) | Anti-Apo-2-antistof | |
| NZ323795A (en) | Isolated nucleic acid molecules encoding AUR-1 (aurora-1) and AUR-2 polypeptides | |
| HUP0002095A2 (hu) | Vegyületek prosztatarák immunterápiás kezelésére és alkalmazásuk | |
| DE60121346D1 (en) | Suppressor-gen | |
| AU2002323120A1 (en) | Periostin-based diagnostic assays | |
| WO2001064877A3 (en) | Human schizophrenia gene | |
| WO1996031603A3 (en) | Methods and compositions for regulating fadd | |
| DE60235985D1 (de) | Ntb-a, ein oberflächenmolekül impliziert in der aktivität natürlicher killerzellen (nk) | |
| DE60031418D1 (de) | 15571, ein neues gpcr-ähnliches molekül der secretin-ähnlichen familie und dessen verwendungen | |
| ATE470478T1 (de) | An ovarialkrebs beteiligtes protein | |
| AU2003222606A1 (en) | Diagnosis of carcinoma using raigi polypeptides | |
| IL207012A0 (en) | Diagnosis and therapy of cancer using sgp28-related molecules | |
| WO2003087840A3 (en) | Protein involved in cancer | |
| WO2002092765A3 (en) | Novel telomerase inhibitors and uses therefor | |
| TR200102655T2 (tr) | Dört L. infantum proteininin antijen belirleyicilerini kodlayan kimerik gen. | |
| WO2001064876A3 (en) | Human schizophrenia gene | |
| WO1999063094A3 (en) | Nucleotide and protein sequences of gpr1 and methods based thereon | |
| WO2002090991A3 (en) | Proteins and genes for diagnosis and treatment of erbb2-related cancer | |
| NZ512332A (en) | Potassium channel interactors and uses therefor | |
| WO2004048549A3 (en) | Dep-1 receptor protein tyrosine phosphatase interacting proteins and related methods | |
| WO2005079490A3 (en) | Methods of therapy and diagnosis using targeting of cells that express steap2 polypeptides |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |